These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31281524)

  • 1. Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome.
    Hao D; Li J; Wang J; Meng Y; Zhao Z; Zhang C; Miao K; Deng C; Tsang BK; Wang L; Di LJ
    Theranostics; 2019; 9(13):3952-3965. PubMed ID: 31281524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and bioinformatics analysis of the relationship between LAMA3 DNA methylation expression and platinum resistance and prognosis in epithelial ovarian cancer].
    Chen CX; Zhang YL; Huang YZ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2024 Jun; 59(6):454-464. PubMed ID: 38951081
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling.
    Wu G; Cao L; Zhu J; Tan Z; Tang M; Li Z; Hu Y; Yu R; Zhang S; Song L; Li J
    Clin Cancer Res; 2019 Feb; 25(3):1022-1035. PubMed ID: 30279231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LDLR-mediated lipidome-transcriptome reprogramming in cisplatin insensitivity.
    Chang WC; Wang HC; Cheng WC; Yang JC; Chung WM; Ho YP; Chen L; Hung YC; Ma WL
    Endocr Relat Cancer; 2020 Feb; 27(2):81-95. PubMed ID: 31815680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells.
    Sun L; Ji WX; Li Y; Li ZL; Duan CC; Xia BR; Xiao L
    J Ovarian Res; 2023 Sep; 16(1):187. PubMed ID: 37684671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer.
    Zhang X; Liu G; Qiu J; Zhang N; Ding J; Hua K
    Sci Rep; 2017 Jun; 7(1):4469. PubMed ID: 28667302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
    Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
    Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
    Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
    Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.
    Mehdi S; Macdonald E; Galpin K; Landry DA; Rodriguez G; Vanderhyden B; Bachvarov D
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2
    Liu L; Cai S; Han C; Banerjee A; Wu D; Cui T; Xie G; Zhang J; Zhang X; McLaughlin E; Yin M; Backes FJ; Chakravarti A; Zheng Y; Wang QE
    Mol Cancer Ther; 2020 Jan; 19(1):199-210. PubMed ID: 31534014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.
    Xiao M; Cai J; Cai L; Jia J; Xie L; Zhu Y; Huang B; Jin D; Wang Z
    J Ovarian Res; 2017 Apr; 10(1):24. PubMed ID: 28376831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers.
    Marzio A; Puccini J; Kwon Y; Maverakis NK; Arbini A; Sung P; Bar-Sagi D; Pagano M
    Mol Cell; 2019 Jan; 73(2):224-237.e6. PubMed ID: 30554948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oestrogen on long noncoding RNA expression in oestrogen receptor alpha-positive ovarian cancer cells.
    Qiu J; Ye L; Ding J; Feng W; Zhang Y; Lv T; Wang J; Hua K
    J Steroid Biochem Mol Biol; 2014 May; 141():60-70. PubMed ID: 24380700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl‑2/Bax and GSK3β/β‑catenin signaling pathways.
    Zhang H; Dong R; Zhang P; Wang Y
    Oncol Rep; 2019 May; 41(5):3069-3079. PubMed ID: 30896826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen induces RAD51C expression and localization to sites of DNA damage.
    Alayev A; Salamon RS; Manna S; Schwartz NS; Berman AY; Holz MK
    Cell Cycle; 2016 Dec; 15(23):3230-3239. PubMed ID: 27753535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
    Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional oxabicycloheptene sulfonate targets the homologous recombination and repair programmes through estrogen receptor α antagonism.
    Wu J; Yan J; Fang P; Zhou HB; Liang K; Huang J
    Cancer Lett; 2020 Jan; 469():78-88. PubMed ID: 31629931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
    Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
    Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression.
    Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.